COVID-19 updates for Saturday, April 17
If you find these round-ups informative, consider supporting to enable updates to continue:
🚨 Rare clotting events are under investigation in connection to at least two brands of COVID-19 vaccines. Here’s my article for about the biological theories that might explain them: theatlantic.com/science/archiv…
Great to see a strong focus on genomic epidemiology from the . Details to be figured out, but the overall plan looks good, putting in a strong position to continue to lead the build-out of genomic sequencing across the country.
Airborne it is. 🦠 The 10 streams of overwhelming evidence thelancet.com/journals/lance… by a 5-★ succinct summary
As India's Covid epidemic worsens, so does prevalence of a "double mutation" variant, which has mutations E484Q (like E484K) and L452R (found in CA variant). Now classified as B.1.617 – it's gone from 24% of sequenced samples in February to 80% on April 1.
With flu, a phenomenon called imprinting sets our immune response to the changeable viruses early in life; it's a boon & a hindrance. Some researchers are concerned the same will happen with , possibly impeding our responses to next-gen vaccines. statnews.com/2021/04/16/nex…
Latest updates and per-state vaccination rates: covidpath.net